Results from a pivotal, open-label, phase II study of romidepsin in relapsed or refractory peripheral T-cell lymphoma after prior systemic therapy (Q33399309)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Results from a pivotal, open-label, phase II study of romidepsin in relapsed or refractory peripheral T-cell lymphoma after prior systemic therapy |
scientific article |
Statements
1 reference
Results from a pivotal, open-label, phase II study of romidepsin in relapsed or refractory peripheral T-cell lymphoma after prior systemic therapy (English)
1 reference
Bertrand Coiffier
1 reference
Barbara Pro
1 reference
H Miles Prince
1 reference
Francine Foss
1 reference
Lubomir Sokol
1 reference
Matthew Greenwood
1 reference
Dolores Caballero
1 reference
Peter Borchmann
1 reference
Franck Morschhauser
1 reference
Martin Wilhelm
1 reference
Lauren Pinter-Brown
1 reference
Andrei Shustov
1 reference
Jean Nichols
1 reference
Susan Carroll
1 reference
John Balser
1 reference
Barbara Balser
1 reference
Steven Horwitz
1 reference
23 January 2012
1 reference
1 reference
Identifiers
1 reference